Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-24

FDA Approved: GABAPENTIN — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves the Gabapentin original ANDA from Zydus Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)